$1.01
-$0.04
(-3.37%)
Quote as of 4:00 PM EST on 02/10/12
Peregrine Pharmaceuticals
NASDAQ:PPHM
Extended Hours:
$1.00
$0.00
(-0.50%)
Quote as of 6:20 PM EST on 02/10/12 (NASDAQ)
|
$1.01
|
|
| Today's Open | $1.03 |
|---|---|
| Previous Close | $1.04 |
| Daily Range | $0.99 - $1.03 |
| 52-Week Range | $0.85 - $2.74 |
| Market Cap | $87.22M |
| P/E Ratio | -1.86 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 1,462,746 |
| Average Daily Volume | 1,368,477 |
| Current FY EPS | -$0.54 |
PPHM Information
| Description |
|---|
| A biopharmaceutical company with a portfolio of clinical stage and pre-clinical product candidates using monoclonal antibodies for the treatment of cancer and viral diseases. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
7 Reasons to Worry About Next Week
Peregrine Pharmaceuticals' CEO Discusses Q4 2011 Results - Earnings Call Transcript
Peregrine Pharma's Secret Weapon
A Simplified ASCO 2011 List for Biotech Investor Research
3 Biotechs With Momentum Ahead of ASCO
20 Stocks Under $3 With Significant Insider Buying
Peregrine Pharmaceuticals' CEO Discusses Q3 2011 Results - Earnings Call Transcript
Peregrine Pharmaceuticals' CEO Discusses Q3 2011 Results - Earnings Call Transcript
Trial News Make Peregrine Pharmaceuticals Worth Watching
